Atika Capital Management LLC Novo Cure LTD Transaction History

Atika Capital Management LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2020 May 14, 2020	SELL	$57.05 - $95.75 $1.83 Million - $3.06 Million	-32,000 Closed	0 $0
Q4 2019 Feb 14, 2020	SELL	$68.3 - $93.8 $388,627 - $533,722	-5,690 Reduced 15.1%	32,000 $2.7 Million
Q3 2019 Nov 14, 2019	BUY	$61.86 - $97.8 $290,742 - $459,660	4,700 Added 14.25%	37,690 $2.82 Million
Q2 2019 Aug 12, 2019	SELL	$42.22 - $63.23 $1.06 Million - $1.58 Million	-25,010 Reduced 43.12%	32,990 $2.09 Million
Q1 2019 May 13, 2019	SELL	$31.96 - $56.12 $79,900 - $140,300	-2,500 Reduced 4.13%	58,000 $2.79 Million
Q4 2018 Feb 14, 2019	SELL	$28.72 - $52.63 $3.92 Million - $7.18 Million	-136,500 Reduced 69.29%	60,500 $2.03 Million
Q3 2018 Nov 14, 2018	BUY	$32.0 - $52.4 $3.42 Million - $5.61 Million	107,000 Added 118.89%	197,000 $10.3 Million
Q2 2018 Aug 14, 2018	BUY	$19.85 - $32.0 $1.79 Million - $2.88 Million	90,000 New	90,000 $2.82 Million

263

76.9M

1.17M

318K

Ticker NVCR
Exchange NASDAQ
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 104,950,000
Market Cap $2.76B
Description
NovoCure Limited, an oncology company, engages in the development, manufacture, and commercialization of tumor treating fields (TTFields) devices for the treatment of solid tumor cancers in the United States, Europe, the Middle East, Africa, Japan, and Greater China. Its TTFields devices include Optune for the treatment of glioblastoma; and Optu...

Get notified when there are updates to the investment portfolio of Atika Capital Management LLC, based on Form 13F filings with the SEC.

Stay updated on Atika Capital Management LLC with notifications on news.